<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Cardiac ]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/cardiac</link>
    <description><![CDATA[Cardiac ]]></description>
    <pubDate>Sun, 12 Apr 2026 23:14:13 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Global Cardiac Rhythm Management Market]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-rhythm-management-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">ResearchCubes Cardiac Rhythm Management Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the  critical & timely requirement of business information of medical devices business leaders.
The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost.


•    What is the current Cardiac Rhythm Management Market size and future potential?  
•    What is the geographical segmentation of the Cardiac Rhythm Management Market? 
•    What are the emerging pipeline products available in the Cardiac Rhythm Management Market?
•    What are the various products currently under development/pipeline in the Cardiac Rhythm Management Market, by category, by product type,...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225876"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 10:32:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Assist Devices Market]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-assist-devices-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">ResearchCubes Cardiac Assist Devices Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the  critical & timely requirement of business information of medical devices business leaders.
The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost.


•    What is the current Cardiac Assist Devices Market size and future potential?  
•    What is the geographical segmentation of the Cardiac Assist Devices Market? 
•    What are the emerging pipeline products available in the Cardiac Assist Devices Market?
•    What are the various products currently under development/pipeline in the Cardiac Assist Devices Market, by category, by product type, by company and...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225877"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 10:32:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Resynchronization Therapy Defibrillator Market]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-resynchronization-therapy-defibrillator-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225886"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 10:32:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Resynchronization Therapy - Market Insights, Competitive Landscape and Market Forecast-2027]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-resynchronization-therapy-market-insights-competitive-landscape</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Cardiac Resynchronization (CRT) Therapy Market By Product Type (CRT-Defibrillators And CRT-Pacemakers), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to register appreciable CAGR growth  till 2027 owing to increasing prevalence of cardiovascular diseases such as heart failure  due to growing prevalence of lifestyle disorders such as hypertension and diabetes.

Global cardiac resynchronization (CRT) therapy market was valued at USD 07.00 billion in 2021, growing at a CAGR of 6.49% during the forecast period from 2022 to 2027 to reach USD 10.18 billion by 2027. The demand for cardiac resynchronization therapy devices is majorly being driven by an increase in geriatric population who form the susceptible at-risk population group for heart failure, rising prevalence of cardiovascular diseases such as coronary artery disease which may further act as a risk factor leading to heart failure,  growing prevalence of lifestyle disorders such as hypertension and diabetes that may impact the health of the heart over a long period of time, innovations in pr...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225004"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 27 Apr 2022 14:02:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Catheter Equipment Market Research Report 2022-2026]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-catheter-equipment-market-research-report-2022-2026</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cardiac Catheter Equipment Report by Material, Application, and Geography – Global Forecast to 2026 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Cardiac Catheter Equipment market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Cardiac Catheter Equipment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-224713"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Apr 2022 14:34:41 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Reader System Market Research Report 2021-2025]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-reader-system-market-research-report-2021-2025</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Cardiac reader system delivers high point of care testing results utilized for diagnosis of heart diseases for example, myocardial infarction and other cardiac related diseases. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cardiac Reader System Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Cardiac Reader System market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Cardiac Reader System basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-220778"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 08 Sep 2021 15:45:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Cardiac Marker Analyzers Market Research Report 2021-2025]]></title>
      <link>https://www.leadingmarketresearch.com/global-cardiac-marker-analyzers-market-research-report-2021-2025</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cardiac Marker Analyzers Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Cardiac Marker Analyzers market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Cardiac Marker Analyzers basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and fo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-220779"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 08 Sep 2021 15:45:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Monitoring Devices Market Insights, Competitive Landscape and Market Forecast–2025]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-monitoring-devices-market-insights-competitive-landscape-and-marke</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s ‘Cardiac Monitoring Devices-Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Cardiac Monitoring Devices market report provides an overview of Cardiac Monitoring Devices, reasons to get Cardiac Monitoring Devices as well as its advantages and limitations. Additionally, the report provides insight on the Cardiac Monitoring Devices market share of the individual Cardiac Monitoring Devices devices, current and forecasted Cardiac Monitoring Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Cardiac Monitoring Devices Overview
Clinicians use cardiac monitoring devices, which are important for cardiovascular care, to assess the occurrence an...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-217515"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 05 Feb 2021 15:36:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Ablation Devices  Market Insights, Competitive Landscape and Market Forecast–2025]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-ablation-devices-market-insights-competitive-landscape-and-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s ‘Cardiac Ablation Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Cardiac Ablation Devices  and the historical and forecasted Cardiac Ablation Devices  market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Cardiac Ablation Devices  market report provides an overview of Cardiac Ablation Devices , reasons to get Cardiac Ablation Devices  as well as its advantages and limitations. Additionally, the report provides insight on the Cardiac Ablation Devices  market share of the individual Cardiac Ablation Devices  devices, current and forecasted Cardiac Ablation Devices  market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Cardiac Ablation Devices  Overview
Cardiac ablation is a surgical technique that can correct cardiac arrhythmias by scarring tiny regions of the heart. Cardiac ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-217553"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 05 Feb 2021 15:36:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Assist Devices  Market Insights, Competitive Landscape and Market Forecast–2025]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-assist-devices-market-insights-competitive-landscape-and-market-f</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s ‘Cardiac Assist Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Cardiac Assist Devices  and the historical and forecasted Cardiac Assist Devices  market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Cardiac Assist Devices  market report provides an overview of Cardiac Assist Devices , reasons to get Cardiac Assist Devices  as well as its advantages and limitations. Additionally, the report provides insight on the Cardiac Assist Devices  market share of the individual Cardiac Assist Devices  devices, current and forecasted Cardiac Assist Devices  market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Cardiac Assist Devices  Overview
Cardiac Assist Devices (CAD) are a type of mechanical pumps that operate together with the heart to increase the effectiveness of pumping and mai...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-217554"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 05 Feb 2021 15:36:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-rhythm-management-market-analysis-size-trends-europe-2019-202</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging global population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR of in the single-digits.

...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-213928"><span class="price">$11,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 25 Feb 2020 15:44:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Rhythm Management, Electrophysiology &amp; Cardiac Ablation Market | US | 2019-2025 | MedSuite]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-rhythm-management-electrophysiology-and-cardiac-ablation-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used
for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are
pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices
(CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators,
electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation
catheters....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212263"><span class="price">$10,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Nov 2019 13:39:22 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-rhythm-management-market-analysis-size-trends-united-states-2</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212264"><span class="price">$10,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Nov 2019 13:39:22 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Rhythm Management, Electrophysiology &amp; Cardiac Ablation Market | US | 2019-2025 | MedSuite]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-rhythm-management-electrophysiology-and-cardiac-ablation-market-91</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used
for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are
pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices
(CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators,
electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation
catheters....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212265"><span class="price">$10,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Nov 2019 13:39:22 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Leadless Cardiac Pacemakers Market Research Report 2019-2023]]></title>
      <link>https://www.leadingmarketresearch.com/global-leadless-cardiac-pacemakers-market-research-report-2019-2023</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">A leadless cardiac pacemaker system is a pulse generator with built-in battery and electrode for implantation in a cardiac chamber via a transfemoral catheter approach. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Leadless Cardiac Pacemakers Report by Material, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). 

In this report, the global Leadless Cardiac Pacemakers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023.

The report firstly introduced the Leadless Cardiac Pacemakers basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208950"><span class="price">$2,850.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 25 Jul 2019 11:27:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Output Monitoring Market Report - United States - 2019-2025]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-output-monitoring-market-report-united-states-2019-2025-medco</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs....





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208868"><span class="price">$3,495.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 08 Jul 2019 15:27:56 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/low-cardiac-output-syndrome-global-clinical-trials-review-h2-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2017&quot; provides an overview of Low Cardiac Output Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Low Cardiac Output Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective co...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200367"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 18 Jan 2018 13:06:38 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[MediPoint: Cardiac Markers Rapid Tests and Point of Care - Global Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/medipoint-cardiac-markers-rapid-tests-and-point-of-care-global-analysis-200347</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances.<br><br>This report focuses on the POC diagnostics market in the 15 major markets (15MM: US, France, Germany, Italy, Spain, UK, Japan, China, India, Brazil, Canada, Mexico, Russia, South Korea, and Australia). In this report, GlobalData evaluates the currently marketed POC products, identifies the unmet needs in each market, analyzes market dynamics, and provides an understanding of physicians&#039; adoption trends for different types of POC products. In order to successfully take advantage of the growing POC diagnostics market, manufacturers are required to adopt strategies that address the current unmet needs, and to concentrate on demonstrating the clinical value of their products, to drive phy...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-197450"><span class="price">$5,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 04 May 2017 12:38:42 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - North America Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-north-america-analysis-and-200349</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-197452"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 04 May 2017 12:38:42 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - Europe Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-europe-analysis-and-market-200350</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-197453"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 04 May 2017 12:38:42 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - South America Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-south-america-analysis-and-200351</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-197454"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 04 May 2017 12:38:42 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - APAC Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-apac-analysis-and-market-fo-200352</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-197455"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 04 May 2017 12:38:42 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[MediPoint: Cardiac Markers Rapid Tests and Point of Care - Global Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/medipoint-cardiac-markers-rapid-tests-and-point-of-care-global-analysis</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances.<br><br>This report focuses on the POC diagnostics market in the 15 major markets (15MM: US, France, Germany, Italy, Spain, UK, Japan, China, India, Brazil, Canada, Mexico, Russia, South Korea, and Australia). In this report, GlobalData evaluates the currently marketed POC products, identifies the unmet needs in each market, analyzes market dynamics, and provides an understanding of physicians&#039; adoption trends for different types of POC products. In order to successfully take advantage of the growing POC diagnostics market, manufacturers are required to adopt strategies that address the current unmet needs, and to concentrate on demonstrating the clinical value of their products, to drive phy...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-193411"><span class="price">$5,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Apr 2017 15:17:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - North America Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-north-america-analysis-and</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-193413"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Apr 2017 15:17:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cardiac Markers Rapid Tests and Point of Care - Europe Analysis and Market Forecasts]]></title>
      <link>https://www.leadingmarketresearch.com/cardiac-markers-rapid-tests-and-point-of-care-europe-analysis-and-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Point-of-care testing (POCT), also known as bedside testing, near-patient testing, or decentralized laboratory testing, is an emerging specialty within in vitro diagnostics (IVD). POCT is one of the most rapidly growing areas in IVD, both due to the drive to increase efficiency and therefore improve patient care, and as a result of significant technological advances. Developments in fluid handling, microchip technology, and improved manufacturing processes are improving sensitivity and enabling miniaturization of point-of-care (POC) diagnostic platforms.<br><br>In recent years, manufacturers have worked to overthrow the image of poor sensitivity and unreliable results previously associated with POCT. Despite several recalls linked to erroneous results, there has been a significant improvement in analytic technologies, which in some cases match the performance of central laboratory testing. These tests have the potential to improve outcomes in primary and acute care by optimizing healthcare delivery to support more patient-centered approaches, and allow for mo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-193414"><span class="price">$4,450.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Apr 2017 15:17:44 +0000</pubDate>
    </item>
  </channel>
</rss>
